Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating expenses:
Research and development	$ 7,886	$ 789	$ 16,908	$ 1,339
General and administrative	4,752	346	10,022	489
Total operating expenses	12,638	1,135	26,930	1,828
Loss from operations	(12,638)	(1,135)	(26,930)	(1,828)
Interest and other income, net	32		73	2
Net loss	(12,606)	(1,135)	(26,857)	(1,826)
Other comprehensive loss:
Unrealized gain on investments, net			2
Comprehensive loss	$ (12,606)	$ (1,135)	$ (26,855)	$ (1,826)
Net loss per common share, basic and diluted	$ (0.43)	$ (0.10)	$ (1.21)	$ (0.18)
Weighted-average number of common shares used to compute basic and diluted net loss per common share	29,001,213	11,724,100	22,105,321	10,082,667